RXI Pharma Stock Price (NASDAQ:RXII)

Add to My Stocks
$1.18 $0.04 (3.28%) RXII stock closing price Sep 18, 2018 (Closing)
Prev Close* : $1.22
Market Cap:
$5.34M
Day Low: $1.18
52 Week Low: $1.18
Open: $1.22
Volume: -
Day High: $1.23
52 Week High: $7.70
Dividend:
0.00

Latest Stock Market News

Latest Articles

RXI Pharma News - From Partners

RXII Stockcharts

View RXII PE ratio, PS ratio stocks charts and compare with peers.
RXII Chart
Note: Compare RXI Pharma stock price history with the index and industry peers.

RXI Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

RXI Pharma Returns

ROE
(return on equity)
-287%

RXI Pharma Financial Ratios

Asset Turnover
0.05
Receivables Turnover
-
Debt to Equity
0
Dividend Yield
-999.0000

RXII Industry Peers

Company Price Change (%)
Pain Therapeutics (PTIE)0.960.01 (1.05%)
Apricus Biosciences (APRI)0.280 (0%)
Novan Inc (NOVN)2.840.03 (1.07%)
Dermira (DERM)10.860.28 (2.65%)
Dicerna Pharma (DRNA)16.930.16 (0.94%)
Fibrocell Science (FCSC)2.160.06 (2.86%)
Revance (RVNC)24.050.5 (2.12%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 18, 2018

RXi Pharmaceuticals Corp Stock News - Partner Headlines

6 Stocks Move Tuesday   on Mar 27, 2018

RXI Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-12.45M-8.99M-10.22M-8.8M-20.92M
Total Operating Expense14.07M9.02M10.26M8.89M21.34M
View RXI Pharma income statement
balance sheet20172016201520142013
Total Assets4.09M13.39M11.15M9.18M14.93M
Total Liabilities2.26M2.54M2.26M1.33M2.07M
Shareholders Equity1.83M10.85M8.89M7.85M12.86M
View RXI Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.53M-1.06M-0.88M-
Net Cash from (used by) Operating Activities-9.51M-7.76M-7.31M-7.75M-6.31M
Increase (Decrease) in Prop Plant And Equipment-0.2M--0.05M-0.08M-0.07M
View RXI Pharma cash flow statement

RXI Pharma Stock Message Board

As of last trading day, RXI Pharma stock price was $1.18. The total market value as denoted by $5.34M for RXI Pharma, is the market value of the company's outstanding shares. RXI Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of RXI Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in RXI Pharma stock quote data shows the number of shares traded. For Ex: 78,593 RXI Pharma shares were traded as of last trading day, as seen from RXI Pharma stock chart. RXI Pharma paid 0.00 stock dividends to its shareholders during last quarter. RXI Pharma stock price history, gives the entire historical data for RXII stock.